Aims & Scope

Immunotherapy Advances publishes scientifically rigorous research relating to manipulations of the immune system for the benefit of human and animal health in all disease areas.

The journal covers the translational pipeline for immunotherapy from discovery research and preclinical animal models through to clinical trials.

Experimental medicine and first-in-human clinical studies are encouraged, and negative clinical trials are welcomed where they contribute to immune-mechanistic insight.

We also recognise the growing importance of interdisciplinary working in this area and encourage studies that are at the interface with engineering, mathematics and computer science, chemistry and the physical sciences.

Topics of interest to the journal include: Manipulations of the immune system for the benefit of human and animal health Immunotherapeutic interventions (such as small molecules, biotherapeutics and therapeutic vaccines) and their mechanism of action in all disease areas Understanding of immunological mechanisms Discovery research through to clinical trials Interdisciplinary research with physical sciences, maths and engineering

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2024 4.10

Journal Rank

Year Value
2024 2218

Journal Citation Indicator

Year Value
2024 306

SJR (SCImago Journal Rank)

Year Value
2024 1.565

Quartile

Year Value
2024 Q1

h-index

Year Value
2024 14

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,205.00 GBP. Learn more.

Explore journals without APCs for alternative publishing options.


Quick Facts

Current Factor
4.10
First Published: 2024

SJR (SCImago Journal Rank)

SJR
1.565
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields